FDA Expands Breath-Actuated Inhaler Use to Kids as Young as 4FDA Expands Breath-Actuated Inhaler Use to Kids as Young as 4

The rescue inhaler ProAir RespiClick offers a new option for younger patients that eliminates the need for hand-breath coordination during inhalation. FDA Approvals
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Pulmonary Medicine News Alert Source Type: news

Related Links:

Conclusions: COS showed anti-allergy properties by regulating the levels of Th1 and Th2 cytokines.Int Arch Allergy Immunol
Source: International Archives of Allergy and Immunology - Category: Allergy & Immunology Source Type: research
Several human polyomaviruses, including Merkel cell polyomavirus, have been isolated on the skin. Which are associated with cutaneous disease, and what do we know about their molecular mechanisms?The British Journal of Dermatology
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Dermatology Journal Article Source Type: news
Injuries from cosmetics, shampoo and other personal care products send one young child to an emergency department in the United States every two hours, according to a new study.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Family Medicine/Primary Care News Source Type: news
Publication date: Available online 22 June 2019Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Danijela Bokanovic, Lisa Arzt-Gradwohl, Ines Schwarz, Christoph Schrautzer, Karin Laipold, Werner Aberer, Barbara Binder, Gunter J. Sturm
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
ConclusionsThe impact of exposure is dose-related and linked to the sensitization step which may subsequently lead to allergy development. For primary prevention of enzyme allergy, exposure control is mandatory and achievable despite increasing production volumes.
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
Publication date: Available online 22 June 2019Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Erika J. Yoo, Nora L. Lee, Kelly P. Huang, Lara T. Kose, Deval Desai, Lauren A. Plante, Edward S. Schulman
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
Publication date: Available online 22 June 2019Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Elise Coulson, Sheryl Rifas-Shiman, Joanne Sordillo, Supinda Bunyavanich, Carlos Camargo, Thomas Platts-Mills, Brent Coull, Heike Luttmann-Gibson, Emily Oken, Diane Gold, Mary Rice
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
ConclusionsThe effectiveness of LTRAs was not different from that of low-dose ICSs regarding the risk of asthma exacerbation in elderly patients with asthma in real-world settings. Given the practical benefits gained from convenient administration, LTRAs can be considered a reasonable alternative first-line therapy for elderly patients with mild asthma.
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
CONCLUSION: Ferulic acids are known to contrarily down-manage an assortment of extracellular and intracellular atomic targets related to infection movement. Various patents on ferulic acid based moieties have been accounted for from 2018. The ferulic acids have a wide scope of impacts against different infections like a malignant growth, diabetes, cardiovascular and neurodegenerative. The current review deals with the antioxidant property of ferulic acid and the recent patent describe the role of ferulic acid against human diseases. PMID: 31223096 [PubMed - as supplied by publisher]
Source: Recent Patents on Inflammation and Allergy Drug Discovery - Category: Allergy & Immunology Tags: Recent Pat Inflamm Allergy Drug Discov Source Type: research
Publication date: Available online 21 June 2019Source: Biosensors and BioelectronicsAuthor(s): Jinru Zhou, Qinqin Qi, Chong Wang, Yifan Qian, Guangming Liu, Yanbo Wang, Linglin FuAbstractFood allergies are recognized as a growing public health concern, with an estimated 3% of adults and 6-8% of children affected by food allergy disorders. Hence, food allergen detection, labeling, and management have become significant priorities within the food industry, and there is an urgent requirement for reliable, sensitive, and user-friendly technologies to trace food allergens in food products. In this critical review, we provide a ...
Source: Biosensors and Bioelectronics - Category: Biotechnology Source Type: research
More News: Allergy | Allergy & Immunology | Children | Proair HFA | Ventolin